Atlas Venture Associates IX, L.P.
Insider CIK 1671208 · UMRX 10% owner · NTLA 10% owner · SURF 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SURF Surface Oncology, Inc. | S Sale | 2020-12-17 | 2020-12-21 | 1,700,000 | $18.10 | $30.77M | 2,945,453 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2020-12-17 | 2020-12-21 | 1,700,000 | $8.10 | $13.77M | 2,945,453 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion deriv | 2018-04-23 | 2018-04-23 | 7,000,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion | 2018-04-23 | 2018-04-23 | 3,181,817 | — | $0 | 4,545,453 | SEC↗ |
| SURF Surface Oncology, Inc. | P Buy | 2018-04-23 | 2018-04-23 | 100,000 | $15.00 | $1.50M | 4,645,453 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion deriv | 2018-04-03 | 2018-04-03 | 83,037 | — | $0 | 0 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion deriv | 2018-04-03 | 2018-04-03 | 3,184,446 | — | $0 | 0 | SEC↗ |
| UMRX Unum Therapeutics Inc. | P Buy | 2018-04-03 | 2018-04-03 | 94,052 | $12.00 | $1.13M | 3,361,535 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion | 2018-04-03 | 2018-04-03 | 83,037 | — | $0 | 3,267,483 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion | 2018-04-03 | 2018-04-03 | 3,184,446 | — | $0 | 3,184,446 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-07-11 | 2017-07-11 | 80,000 | $16.07 | $1.29M | 3,579,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-07-10 | 2017-07-11 | 40,000 | $16.17 | $646.8K | 3,659,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-07-07 | 2017-07-11 | 30,000 | $16.77 | $503.1K | 3,699,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-03-10 | 2017-03-13 | 5,504 | $14.06 | $77.4K | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-03-09 | 2017-03-13 | 15,628 | $13.85 | $216.4K | 5,504 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | J Other | 2017-03-03 | 2017-03-07 | 700,000 | — | $0 | 3,729,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 3,809,524 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 1,333,333 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 761,905 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 946,237 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 862,120 | — | $0 | 3,937,148 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 611,827 | — | $0 | 611,827 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 492,640 | — | $0 | 4,429,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 2,463,201 | — | $0 | 3,075,028 | SEC↗ |